Search All UT System Experts

Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors

Mark W. Kieran, Jeffrey G. Supko, Dana Wallace, Robert Fruscio, Tina Young Poussaint, Peter Phillips, Ian Pollack, Roger Packer, James M. Boyett, Susan Blaney, Anu Banerjee, Russ Geyer, Henry Friedman, Stewart Goldman, Larry E. Kun, Tobey MacDonald

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences